« FDA announces recall of Abbott glucose test strips glucose test | Main | FDA Approvals - FDA CONSUMER HEALTH INFORMATION - Generic Drug Roundup: December 2010 »

Xanodyne agrees to withdraw propoxyphene from the U.S. market Xanodyne


Xanodyne agrees to withdraw propoxyphene from the U.S. market
Xanodyne Pharmaceuticals Inc. which makes Darvon and Darvocet, the brand version of the painkiller propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food Administration. The FDA has also informed generic manufacturers of Xanodyne s decision and they will be removing their propoxyphene-containing products from the market as well.
 

©2006 FDA-News.com. All rights reserved.